Korean J Fam Med. 2011 Sep;32(6):334-40. doi: 10.4082/kjfm.2011.32.6.334. Epub 2011 Sep 28.
Association of heart rate variability with the framingham risk score in healthy adults.
Korean journal of family medicine
Cheol Seung Yoo, Kayoung Lee, Sang Hoon Yi, Jun-Su Kim, Hee-Cheol Kim
Affiliations
Affiliations
- School of Computer Aided Science & Institute of Basic Science, Inje University, Gimhae, Korea.
PMID: 22745871
PMCID: PMC3383143 DOI: 10.4082/kjfm.2011.32.6.334
Abstract
BACKGROUND: The aim of this study was to investigate the relationship between heart rate variability (HRV), the Framingham risk score (FRS), and the 10-year risk of coronary heart disease (CHD) development among Korean adults.
METHODS: The subjects were 85 healthy Korean adults recruited from a health check-up center. The FRS and 10-year risk of CHD development were calculated.
RESULTS: The FRS in men was inversely correlated with the standard deviation of all normal to normal RR-intervals (SDNN); the root mean square successive difference (RMSSD); the percentage of successive normal cardiac inter-beat intervals greater than 20 ms, 30 ms, and 50 ms (pNN20, pNN30, pNN50); the low frequency (LF); and the high frequency (HF) (P < 0.05). There was no significant relationship between the FRS and HRV in women. Overall, in the receiver operating characteristic (ROC) analysis, the RMSSD, HF, SDNN, LF, LF/HF ratio, and pNN30 predicted an increased 10-year CHD risk. After adjusting for sex and body mass index, those with greater than one standard deviation in the RMSSD, HF, and LF had a 52-59% reduction in their 10-year risk of CHD development ≥ 10%.
CONCLUSION: This study therefore indicates that the HRV indices, particularly SDNN, RMSSD, pNN30, LF, and HF may be useful parameters for the assessment of CHD risk. Most notably, the usefulness of these HRV measures as indicators for CHD risk evaluation may be greater among men than among women.
Keywords: Electrocardiography; Heart Rate; Risk Assessment
References
- Circulation. 2000 Jun 13;101(23):E215-20 - PubMed
- Am J Cardiol. 2004 Feb 1;93(3):381-5 - PubMed
- Circulation. 1996 Mar 1;93(5):1043-65 - PubMed
- Am J Cardiol. 2000 Aug 1;86(3):309-12 - PubMed
- Circulation. 1990 Aug;82(2 Suppl):I103-13 - PubMed
- Am J Epidemiol. 2003 Dec 1;158(11):1058-67 - PubMed
- Atherosclerosis. 1999 Jul;145(1):181-6 - PubMed
- Diabetes. 2002 Dec;51(12):3524-31 - PubMed
- Circulation. 2000 Sep 12;102(11):1239-44 - PubMed
- Am J Cardiol. 1993 Oct 15;72(12):897-903 - PubMed
- Circulation. 2000 May 23;101(20):2398-404 - PubMed
- Circ Res. 1986 Aug;59(2):178-93 - PubMed
- Circulation. 1990 Apr;81(4):1217-24 - PubMed
- Circulation. 2000 Jan 4-11;101(1):8-10 - PubMed
- Circulation. 1996 Dec 1;94(11):2850-5 - PubMed
- Heart. 2002 Oct;88(4):378-80 - PubMed
- Circulation. 1998 May 12;97(18):1837-47 - PubMed
- Hypertension. 2003 Dec;42(6):1106-11 - PubMed
- Am J Cardiol. 1999 Apr 15;83(8):1242-7 - PubMed
- Hypertension. 1998 Aug;32(2):293-7 - PubMed
- Int J Cardiol. 2010 May 28;141(2):122-31 - PubMed
- Am J Cardiol. 1993 Oct 1;72(11):821-2 - PubMed
- Am J Cardiol. 1990 Jan 1;65(1):84-8 - PubMed
Publication Types